Advanced search
Publication Cover
Journal of Addictive Diseases Volume 35, 2016 - Issue 4
Submit an article Journal homepage
853
Views
9
CrossRef citations to date
0
Altmetric
Articles

Efficacy and safety of a sublingual buprenorphine/naloxone rapidly dissolving tablet for the treatment of adults with opioid dependence: A randomized trial

Lynn WebsterPRA Health Sciences, Salt Lake City, Utah, USACorrespondence[email protected]
, MD, FACPM, FASAM,
Peter HjelmströmOrexo AB, Uppsala, Sweden
, MD, PhD,
Michael SumnerOrexo US, Inc., Morristown, New Jersey, USA
, MB, BS, MRCP (UK) &
Erik W. GundersonUniversity of Virginia, Charlottesville, Virginia, USA
, MD, FASAM
Pages 325-338 | Published online: 14 Jul 2016

Citations (9)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Suprit Parida, Kathleen M. Carroll, Ismene L. Petrakis & Mehmet Sofuoglu. (2019) Buprenorphine treatment for opioid use disorder: recent progress. Expert Review of Clinical Pharmacology 12:8, pages 791-803.
Read now
James Kenworthy, Yunni Yi, Antony Wright, Jim Brown, Ana Maria Madrigal & William C. N. Dunlop. (2017) Use of opioid substitution therapies in the treatment of opioid use disorder: results of a UK cost-effectiveness modelling study. Journal of Medical Economics 20:7, pages 740-748.
Read now

Articles from other publishers (7)

Tao Wang, Xun Zhu, Hyun Yi, Jun Gu, Shue Liu, Sari Izenwasser, Vance P Lemmon, Sabita Roy & Shuanglin Hao. (2021) Viral vector-mediated gene therapy for opioid use disorders. Experimental Neurology 341, pages 113710.
Crossref
Bethea A. Kleykamp, Marta De Santis, Robert H. Dworkin, Andrew S. Huhn, Kyle M. Kampman, Ivan D. Montoya, Kenzie L. Preston, Tanya Ramey, Shannon M. Smith, Dennis C. Turk, Robert Walsh, Roger D. Weiss & Eric C. Strain. (2019) Craving and opioid use disorder: A scoping review. Drug and Alcohol Dependence 205, pages 107639.
Crossref
Kathryn Dalton & Natalie Butt. (2019) Does the Addition of Naloxone in Buprenorphine/Naloxone Affect Retention in Treatment in Opioid Replacement Therapy?. Journal of Addictions Nursing 30:4, pages 254-260.
Crossref
Young-A Heo & Lesley J. Scott. (2018) Buprenorphine/Naloxone (Zubsolv®): A Review in Opioid Dependence. CNS Drugs 32:9, pages 875-882.
Crossref
Mellar P. Davis, Gavril Pasternak & Bertrand Behm. (2018) Treating Chronic Pain: An Overview of Clinical Studies Centered on the Buprenorphine Option. Drugs 78:12, pages 1211-1228.
Crossref
Richard J. Bodnar. (2018) Endogenous Opiates and Behavior: 2016. Peptides 101, pages 167-212.
Crossref
Ryan Graddy & Darius A. Rastegar. (2017) Impact of a Mandated Change in Buprenorphine Formulation. Journal of Addiction Medicine 11:6, pages 435-439.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.